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a b s t r a c t
The efﬁcacy of ivermectin (IVM) against gastrointestinal nematodes in Danish cattle was assessed by
faecal egg count reduction test (FECRT). Six cattle farms with history of clinical parasitism and aver-
mectin use were included. On the day of treatment (Day 0), 20 naturally infected calves per farm (total
n ¼ 120) were stratiﬁed by initial faecal egg counts (FEC) and randomly allocated to a treatment group
dosed with 0.2 mg IVM kg1 body weight s.c. (IVM; n ¼ 10) or an untreated control group (CTL; n ¼ 10).
Individual FEC were obtained at Day 0 and Day 14 post-treatment and pooled faeces by group were
cultured to isolate L3 for detection of Ostertagia ostertagi and Cooperia oncophora by qPCR. Treatment
efﬁcacies were analysed using the recommended WAAVP method and two open-source statistical pro-
cedures based on Bayesian modelling: ‘eggCounts’ and ‘Bayescount’. A simulation study evaluated the
performance of the different procedures to correctly identify FEC reduction percentages of simulated
bovine FEC data representing the observed real data. In the FECRT, reduced IVM efﬁcacy was detected in
three farms by all procedures using data from treated animals only, and in one farm according to the
procedures including data from treated and untreated cattle. Post-treatment, O. ostertagi and
C. oncophora L3 were detected by qPCR in faeces of treated animals from one and three herds with
declared reduced IVM efﬁcacy, respectively. Based on the simulation study, all methods showed a
reduced performance when FEC aggregation increased post-treatment and suggested that a treatment
group of 10 animals is insufﬁcient for the FECRT in cattle. This is the ﬁrst report of reduced anthelmintic
efﬁcacy in Danish cattle and warrants the implementation of larger surveys. Advantages and caveats
regarding the use of Bayesian modelling and the relevance of including untreated cattle in the FECRT are
discussed.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Grazing cattle are continuously exposed to infection with
gastrointestinal nematodes (GIN) that can severely impair the
health and productivity of pasture-based livestock systems
(Corwin, 1997; Shaw et al., 1998; Charlier et al., 2014). In practice,
the control of GIN in cattle largely relies on the routine use of
anthelmintic drugs, mainly from the macrocyclic lactone (ML)
family (Vercruysse and Rew, 2002; Geurden et al., 2015). As a
consequence, worm populations resistant to MLs have been
selected, and anthelmintic resistance (AR) is now becoming a
serious threat to the control of bovine nematodes in several
countries (Sutherland and Leathwick, 2011; Gasbarre, 2014;
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Sutherland and Bullen, 2015). Coinciding with the development of
AR, concerns regarding the prophylactic use of veterinary drugs and
chemical residues in both food and environment have led to stricter
regulations on the use of anthelmintics in some nations
(Thamsborg et al., 1999). In 1999, Denmark became the ﬁrst country
to introduce prescription-only use of anthelmintics in livestock,
requiring a mandatory veterinary diagnosis before treatment in
both organic and conventional farms (Anonymous, 1998, 2013).
Since 2000, there has been an additional requirement for all pre-
scriptions in production animals to be registered in ‘VetStat’ e the
Danish system for surveillance of the veterinary use of drugs (Stege
et al., 2003). Preliminary analyses in VetStat indicate that MLs
accounted for ~85% of all anthelmintics prescribed for Danish cattle
between 2010 and 2012, with ivermectin (alone or in combination)
representing 72% of all ML prescribed (Pe~na-Espinoza et al., un-
published data). However, and despite the signiﬁcance of iver-
mectin for current parasite control strategies in cattle, its ﬁeld
efﬁcacy against GIN has not been investigated in Denmark.
In the absence of quantitative molecular techniques for the
detection of ML-resistance, and the high cost of the controlled ef-
ﬁcacy test (the current gold standard method for veriﬁcation of
anthelmintic activity; Wood et al., 1995), the only readily available
technique for investigating ﬁeld drug efﬁcacy is the faecal egg
count reduction test (FECRT). This technique estimates the efﬁcacy
of an anthelmintic to reduce the faecal egg counts (FEC) of infected
animals based on measurements pre- and post-treatment, or be-
tween treated and untreated individuals. The major advantages of
the FECRT are that all drugs can be tested regardless of active
compounds or formulation and that it relies on FEC detection
methods readily available in most diagnostic laboratories. The
current recommendations to conduct and analyse FECRT in cattle
derive from guidelines by the World Association for Advancement
of Veterinary Parasitology (WAAVP), which were originally devel-
oped for detection of AR in sheep nematodes (Coles et al., 1992).
However, potential limitations have been highlighted concerning
the use of FECRT with bovine nematodes, mainly due to the lower
faecal egg excretion of cattle, compared to sheep, and the highly
aggregated distribution of FEC in cattle groups (Coles, 2002; Coles
et al., 2006; Demeler et al., 2010; El-Abdellati et al., 2010; Suther-
land and Leathwick, 2011). These factors may limit the correct
analysis of FECRT data and inference of drug efﬁcacy in cattle using
the WAAVP guidelines. More recently, Bayesian modelling using
Markov chain Monte Carlo (MCMC) methods have been advocated
as robust statistical analyses to cope with low and aggregated FEC
data (Denwood et al., 2010; Torgerson et al., 2014). These MCMC-
based procedures, available as open-source R packages or web-
interface software, are being increasingly used to infer drug efﬁ-
cacy and to monitor AR in horse nematodes (Denwood et al., 2010;
Fischer et al., 2015) and cattle helminths (Neves et al., 2014;
O'Shaughnessy et al., 2014; Geurden et al., 2015; Novobilský and
H€oglund, 2015; Ramos et al., 2016). However, the performance of
these MCMC procedures with the low mean FEC and parasite ag-
gregation levels commonly found in cattle has not yet been eval-
uated. In addition, sensitive and species-speciﬁc tests to detect
which GIN species survive treatment are critical for the surveillance
of AR and are urgently required for cattle (Coles, 2002; Sutherland
and Leathwick, 2011).
The objectives of the present study were: 1) to assess the efﬁ-
cacy of ivermectin (IVM) against GIN in naturally infected Danish
cattle by FECRT, and 2) to evaluate the performance of different
statistical approaches for estimating drug efﬁcacy using simulated
bovine FEC data of similar characteristics to those observed in
Danish cattle. In addition, we investigated the prescription patterns
of anthelmintics in the study farms in order to examine a possible
relationship between previous use of avermectins and IVM efﬁcacy
in the FECRT.
2. Materials and methods
2.1. Selection of farms
Cattle farms (~50) with a history of clinical parasitism were
contacted through local veterinarians across Denmark during
spring 2013 and 2014. The farmers were offered free FEC analyses
and evaluation of anthelmintic efﬁcacy by FECRT. Farms were
selected based on the following criteria: herd size 20 ﬁrst-season
grazing (FSG) calves with 4 weeks of grazing (before the initial
screening) and not treated with anthelmintics within 8 weeks prior
to sampling. In addition, the availability of a cattle crush or barn
was required for the handling of animals. A total of 19 farms (8 in
2013 and 11 in 2014) that fulﬁlled these criteria accepted the
invitation. Individual faecal samples were collected from 20 FSG
calves in each farm between mid-June and early September of 2013
and 2014 for analysis of FEC (initial screening). Due to a lownumber
of farms with mean FEC >150 strongyle eggs per g (epg) of faeces
(as recommended by Coles et al., 1992), farms with a mean
FEC  75 epg were selected for the FECRT. Of the six farms ﬁnally
included in the study, one herd was a conventional beef farm (farm
#1), three were organic dairy farms (#2, #4 and #6), one was an
organic beef farm (#5) and one was a conventional dairy farm (#3).
In Denmark, organic cattle farms should by law provide access to
pasture from 15 April until 1 November (Anonymous, 2016), while
conventional farms do not have to comply with this rule. The cattle
breeds in the investigated farms were Danish Holstein crossbreeds
(#1 and #5), Danish Holstein (#2, #3, and #6) and Danish Jersey
(#4). All the selected farms were located in the Jutland Peninsula
and the FECRT was conducted within one to four weeks after the
initial screening.
2.2. Faecal egg count reduction test (FECRT)
The FECRT was performed to test the efﬁcacy of IVM based on
WAAVP recommendations (Coles et al., 1992). Pre- and post-
treatment faecal samples from treated and untreated animals
were included, and a total of 120 FSG calves were enrolled in the
FECRT studies. On the day of treatment (Day 0), 20 FSG animals
from each farm were stratiﬁed by FEC (based on the initial
screening) and randomly allocated to a treatment group (IVM;
n ¼ 10) or an untreated control group (CTL; n ¼ 10) of similar
(initial) mean FEC. Due to a limited number of animals available in
farms #4 and #6 at the start of the FECRT, the CTL groups at these
properties consisted of nine calves. Oral formulations of IVM are
not registered for use in cattle in Denmark, thus injectable IVMwas
used. At Day 0, individual body weights (BW) were estimated in the
IVM group using a girth tape for cattle (Rondo combi®, Kruuse,
Denmark), and the calves in the treatment group were injected
with the recommended dose of IVM (0.2 mg kg1 BW s.c., Ivomec®
10 mg/mL, Merial Norden A/S). A comparison of BW estimations
between girth tape and electronic scale in a group of 30 FSG calves
(BW range ¼ 84e172 kg) was performed prior to the study and
demonstrated a very high correlation between the methods
(Pearson's correlation ¼ 0.98). Faecal samples were collected
rectally from all animals on Day 0 and 14 days post-treatment (Day
14). Immediately after collection, the faecal samples were vacuum
packed (Freshield Touch, CSE Co, Gyeonggi-do, Korea) to create
anaerobic conditions and transported to the laboratory in a cooling
box. On all farms, animals in the IVM and CTL groups grazed
together on the same pastures until Day 14, when all control calves
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were treated with the recommended dose of injectable IVM as
described above.
2.3. Parasitological analyses
Upon arrival at the laboratory, faecal samples were refrigerated
at 5 C until analysis. Individual FEC were determined using an
accredited, modiﬁedMcMaster techniquewith a sensitivity of 5 epg
(Henriksen and Aagard, 1975). At Day 0 and Day 14, pooled larval
cultures were prepared from the IVM and CTL groups by mixing
10 g of faeces from each animal of the same group into a pool,
which was then cultured according to Roepstorff and Nansen
(1998). After 14 days of incubation at 20 C, nematode L3 were
recovered by Baermannisation and stored at 12 C. A small number
of L3 were harvested in the post-treatment larval cultures from
farms #1, #2, #5 and #6 (<40 larvae per group). All pooled L3 were
used for molecular detection of Ostertagia ostertagi and Cooperia
oncophora by real-time quantitative PCR (qPCR).
2.4. Species-speciﬁc identiﬁcation of nematode larvae by qPCR
Molecular detection of O. ostertagi and C. oncophora in the
pooled L3 suspensions was performed using the qPCR method
described by H€oglund et al. (2013), with modiﬁcations. Brieﬂy, all
L3 pooled per group were concentrated by centrifugation and
transferred into a 2 mL cryotube. Larvae (in 200 ml of tap water)
were mixed with 1 mL buffer ATL (QIAGEN, Germany) and 600 ml of
0.5 mm Zirconia beads (BioSpec Products, USA) and homogenised
by bead-beating for 1 min at 6.5 m/s (FastPrep®-24, MP Bio-
medicals, USA). Subsequently, the suspensionwas digested at 56 C
for 60 min using 20 ml of Proteinase K (20 mg/mL, QIAGEN, Ger-
many) following manufacturer's instructions. Genomic DNA was
extracted from the digested larval homogenate by QIAamp® DNA
Mini Kit (QIAGEN, Germany). For qPCR analyses, primers and
probes targeting the second internal transcribed spacer (ITS-2) of
the ribosomal DNA of O. ostertagi and C. oncophora were used
(H€oglund et al., 2013). ITS-2 copies of both nematode species were
quantiﬁed by correlating cycle threshold (Ct) values to a standard
curve with 2  107, 2  106, 105, 104 and 103 molecules ml1 of stock
plasmid DNA. The plasmid DNA was made from a pCR® 2.1 vector
(Thermo-Fischer Scientiﬁc, USA) that comprised ITS-2 sequences of
C. oncophora (GenBank® accession no. AB245040.2, position 651-
729) and O. ostertagi (GenBank® accession no. AB245021.2, position
1036-1126) (H€oglund et al., 2013). The reactions were run in a
Rotor-Gene Q RG-6000® (QIAGEN, Germany) in total volumes of
25 ml using 2 ml DNA as a template. The PCR mix contained 0.65 U
Taq2000® polymerase (Agilent Technologies, USA), 0.3 mM forward
and reverse primers, 0.2 mM probe, 200 mM dNTP and 5.5 mM
MgCl2. Rotor-Gene Q® series software (QIAGEN, Germany)was used
to determine Ct values for each run. The cycling conditions were
95 C for 10 min and 50 cycles of ampliﬁcation (95 C, 15 s, 62 C,
60 s). All samples and standards were carried out in technical du-
plicates, with exception of the standard curves which were carried
out in triplicates. Sensitivity and speciﬁcity of the qPCRmethodwas
97.2% (95% conﬁdence interval [CI] ¼ 83.8e100%) and 83.3% (95%
CI ¼ 36.4e99%), respectively, based on analyses of spiked larval
samples (n ¼ 42) containing known numbers of mixed or pure
O. ostertagi and/or C. oncophora L3 (unpublished results).
2.5. Use of anthelmintics in the selected farms between 2002 and
2012
Recordings of all anthelmintics prescribed between 2002 and
2012 in the six farms selected for the FECRT were extracted from
the VetStat database (Stege et al., 2003). In Denmark, every veter-
inary drug prescribed for production animals is dispensed to
farmers by ofﬁcial pharmacies or by veterinary practitioners. The
dispensing pharmacy or veterinarian must register in VetStat the
total amount of a speciﬁc drug sold to the farmer, the farm identity,
the animal species and the age groupwhich received the prescribed
treatment. In VetStat, cattle are divided into three age groups: 1)
calves <12 months old (heifer and bull calves); 2) young cattle  12
months old (heifers until ﬁrst calving and steers until slaughter)
and 3) adult cattle (cows after ﬁrst calving). For the study of
anthelmintic use, data retrieved included the name and active
compound of the prescribed anthelmintic, the formulation and
total amount (in total mL or g) of the drug prescribed, and the
targeted cattle age group. However, the exact number of treatments
actually performed in each prescription is not recorded in VetStat.
We therefore estimated the number of treatments for each pre-
scription in the ‘targeted’ group (i.e. calves, young cattle or adult
cattle) within each farm using the total amount of a prescribed drug
(exact data from VetStat), the recommended dose of a given
anthelmintic (considering its formulation) and a deﬁned BW for
each cattle age group. The deﬁned BW for each age group was
estimated based on data from the Danish Cattle Association
(Danmap, 2012) and considering common anthelmintic treatment
practices in each group as: 200 kg BW for calves, 450 kg BW for
young cattle and 620 kg BW for adult cattle. Due to this deﬁned
BWs and the likely variation in the actual amount of active com-
pound used for different animals following each prescription, the
calculated number of treatments is only a proxy of the real number
of animals treated. In addition, it was assumed that anthelmintics
delivered to farmers were used within a month, which may not
always have been the case; however, this potential bias is pre-
sumably consistent across the different drugs and age groups. The
number of animals per age group in each farm at the prescription
date was retrieved from the Central Husbandry Register (Ministry
of Environment and Food of Denmark, http://chr.fvst.dk, accessed
on 15 March 2016). The efﬁcacy of previously used anthelmintics
had not been tested in any of the six farms prior to the study.
2.6. Estimation of treatment efﬁcacy
The efﬁcacy of IVM in the FECRT was analysed by calculating the
arithmetic mean FEC reduction percentage (FECR%) with 95% CI
using the recommendedWAAVPmethod and two procedures using
Bayesian MCMC methods:
2.6.1. WAAVP
Following recommended WAAVP guidelines (Coles et al., 1992)
as: i) FECR% (With CTL)¼ 100 (1[T2/C2]), where T2 and C2 are the
arithmetic mean FEC of the IVM and CTL group at Day 14, respec-
tively, and ii) FECR% (No CTL) ¼ 100  (1[T2/T1]), where T1 and T2
are the arithmetic mean FEC of the IVM group at Day 0 and 14,
correspondingly. The calculations of FECR% and 95% CI with the
WAAVP method were performed according to Coles et al. (1992) in
Microsoft Excel® 2010.
2.6.2. EggCounts
Using the Bayesian MCMC procedure implemented in ‘egg-
Counts’ (version 1.1e1) described by Torgerson et al. (2014). The
analyses were performed via the freely available web interface of
the procedure (available at: http://shiny.math.uzh.ch/user/furrer/
shinyas/shiny-eggCounts/; visited on 01 September 2016). This
software is also available as an R package (Wang et al., 2016). The
eggCounts procedure uses MCMC to ﬁt a model using a gamma-
Poisson distribution for pre- and post-treatment FEC data, thus
accounting for aggregation in FEC data and the Poisson errors of the
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egg counting process, to generate the FECR%with 95% CI (Torgerson
et al., 2014). The procedure uses a single prior for the over-
dispersion parameter (aggregation). Two model options are avail-
able using the eggCounts web interface: i) the unpaired model,
which models pre- and post-treatment data as independent
gamma-Poisson distributions, with a scaled mean and common
aggregation parameters, and ii) the paired model, which ﬁts a
gamma-Poisson distribution to the pre-treatment data only and
scales the means of the Poisson processes from each individual by
the same constant to model the mean of the Poisson processes
representing the post-treatment data. Therefore in the paired
model, pre- and post-treatment mean FEC come from the same
Poisson distribution (i.e. this assumes that the degree of FEC ag-
gregation does not change post-treatment relative to the pre-
treatment). Both models are available with or without a zero-
inﬂation component. For comparison, we used both paired and
unpaired models to analyse our FECRT data, with the default
moderately informative prior distributions as described by Paul
et al. (2014) and Wang et al. (2016), without zero-inﬂation. A
correction factor of 5 epg was applied to the data (to obtain the
number of eggs counted) and FEC data from only the IVM group at
Day 0 and 14 were used (No CTL), as the software currently does not
incorporate the FEC variation of a separated CTL group.
2.6.3. Modiﬁed Bayescount
Using a model based on that implemented by the Bayesian
MCMC ‘Bayescount’ procedure described by Denwood et al. (2010)
and Geurden et al. (2015). The Bayescount paired model describes
the pre-treatment FEC data as a compound gamma-gamma-
Poisson distribution, with the ﬁrst gamma distribution reﬂecting
the variation between animals and the second gamma-Poisson
(negative binomial) distribution describing the variation in
observed FEC that would be expected with repeated samples from
the same animal. The post-treatment FEC data is modelled as a
separate gamma-Poisson (negative binomial) distribution based on
the estimated mean for that animal, and scaled by the FECR%. The
procedure provides the 95% CI of the FECR%, while accounting for
the FEC aggregation between individuals and for the Poisson errors
of the egg counting method. The model is also able to separate the
between- and within-animal FEC variation, and allows for changes
in the FEC aggregation of post-treatment data relative to the cor-
responding pre-treatment observation from the same animal. This
increases the uncertainty in the estimates compared with
assuming that FEC aggregation is identical at Day 0 and 14, but
allows for potential differences in drug efﬁcacy between animals to
result in a higher FEC aggregation post-treatment. Further
description of the method can be found in the appendix of Geurden
et al. (2015). Furthermore, for the present study the Bayescount
paired model was modiﬁed to incorporate the FEC data from the
initial screening in each farm and to model the data from all six
herds simultaneously, therefore allowing for pooling of one or
more variance parameters between farms. As a result, the pro-
cedure allows inference to be made on three FEC variability (ag-
gregation) estimates (k) separately: i) the expected variability
between the unobserved true mean of the animals (between-ani-
mal pre-treatment k); ii) the expected variability between pre-
treatment samples from the same animal (within-animal pre-
treatment k) and iii) the expected variability between post-
treatment samples from the same animal (within-animal post-
treatment k, which also captures variation in the true efﬁcacy be-
tween animals). The mean FEC from each time point was modelled
independently in each farm, so that no pooling of mean FEC or FECR
% parameters took place between herds. Minimally informative
DuMouchel priors (Denwood, 2016) were used for the mean FEC
and various k parameters, and a Beta(1,1) prior was used for the
FECR% and 95% CI estimates. Using this modiﬁed Bayescount
model, the efﬁcacy of IVM in the FECRT studies was evaluated
considering i) the FEC variation in the IVM and CTL groups between
Day 0 and 14 (With CTL), and ii) the FEC variation only in the IVM
group between Day 0 and 14 (No CTL). All FEC data were trans-
formed to the number of eggs counted (FEC divided by 5) for
analysis. All modelling was performed in JAGS (Plummer, 2003)
using the ‘runjags’ package (Denwood, 2016) in R version 3.2.2 (R
Core Team, 2015), with convergence assessed both visually and
using the Gelman-Rubin statistic. Full model code can be obtained
from the corresponding author.
The ﬁt of all MCMCmodels to the FECRT datawas assessed using
the Deviance Information Criterion (DIC) (Spiegelhalter et al.,
2002). For the modiﬁed Bayescount procedure, DIC was used to
compare the ﬁt of models with between- and within-animal k
parameters estimated separately or pooled between farms. For the
eggCounts procedure, DIC was obtained using JAGS models with
identical formulations to those used by eggCounts (Wang et al.,
2016) to compare the ﬁt of the paired vs. unpaired models.
2.7. Interpretation of treatment efﬁcacy
Results with the methods described in Section 2.6 were used to
estimate the efﬁcacy of IVM treatments based on the obtained FECR
% and lower 95% CI as recommended by Coles et al. (1992), as well
as the upper 95% CI as suggested by Lyndal-Murphy et al. (2014),
from which we categorised three conditions:
i) Efﬁcacious treatment, whenmean FECR% and upper CI 95%
and lower CI  90%;
ii) Reduced efﬁcacy, when mean FECR% and upper CI < 95% and
lower CI < 90%;
iii) Inconclusive, when none of the above conditions were met.
2.8. Simulation study
A simulation study was carried out to compare the performance
of the methods outlined in Section 2.6. For this study, we analysed
the FECR% between Day 0 and 14 in simulated treatment groups
(without untreated animals) with different levels of FEC aggrega-
tion. Datasets were simulated based on hierarchical gamma-
gamma-Poisson distributions with parameter estimates obtained
from the modiﬁed Bayescount procedure as described in Section
2.6 and applied to the real FECRT data. Based on the ﬁt of these
models, we assumed that pre-treatment k is ﬁxed between farms
(i.e. not herd dependent), but that post-treatment k varies (inde-
pendently) between herds. As a result, a total pre-treatment k¼ 0.8
(divided into between-animal pre-treatment k ¼ 1.3 and within-
animal pre-treatment k ¼ 4.1) were used for all simulations.
Three different total post-treatment k parameters were simulated:
k ¼ 0.8 (no change of FEC aggregation between Day 0 and 14),
k ¼ 0.3 (moderately increased FEC aggregation between Day 0 and
Day 14) and k ¼ 0.1 (substantially increased FEC aggregation be-
tween Day 0 and Day 14). Pre-treatment (Day 0) FEC datasets were
simulated with sample sizes of n ¼ 10, 20, 30 and 40 and a mean
FEC of 34 eggs counted (equal to 170 epg using a FECmethod with a
detection limit of 5 epg), using the same paired model as described
for the modiﬁed Bayescount procedure. Post-treatment (Day 14)
data were simulated using a FECR% of 85% or 97%. This procedure
was repeated 500 times for each combination of the (two) simu-
lated FECR%, (three) total post-treatment k levels and (four) sample
sizes described (i.e. representing the results of 500 different
treatment groups for each set of parameters). Each of the simulated
datasets were then analysed using i) the WAAVP procedure, ii) the
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paired and unpaired eggCounts procedures implemented using the
eggCounts package version 1.1e1 (Torgerson et al., 2014), and iii)
the standard (unmodiﬁed) Bayescount paired model procedure
using equivalent (moderately informative) priors to those used by
eggCounts in order to facilitate comparison. The mean FECR% and
95% CI obtained for a given simulated dataset using each procedure
were recorded, and the performance of the procedures was
investigated by studying the probability of the simulated FECR%
being included in the 95% CI (i.e. coverage probability of the 95% CI)
along with the uncertainty of the 95% CI (i.e. the relative size of the
95% CI) provided by each procedure. All data simulation and
analysis procedures were performed in R version 3.2.2 (R Core
Team, 2015).
3. Results
3.1. Initial screening of farms
Faecal egg count data observed in groups of 20 FSG calves from
the 19 farms initially screened are summarised in Table 1. A total of
380 animals were sampled duringmid-June and early September of
2013 and 2014. Strongyle eggs were detected on all properties but
very low egg excretion levels (mean FEC  44 epg) were seen in 12
farms (63%). All six farms selected for the FECRT had an initial
arithmetic mean FEC 75 epg.
3.2. FECRT
At Day 0, IVM groups in farms #5 and #6 had a very low mean
FEC (55 epg). In farm #6, three calves in the IVM group could not
be sampled at Day 14 and were excluded from the analyses. In the
model ﬁtting analyses, the eggCounts unpaired and the modiﬁed
Bayescount with pooled pre-treatment k between farms (herd
dependent) and separate post-treatment k between farms (herd
independent) had the lowest DIC values (data not shown), offering
the best ﬁt for the FECRT data, and were therefore selected for the
ﬁnal FECR% analyses.
Results of the FECR% analyses using the WAAVP method and the
selected eggCounts and modiﬁed Bayescount procedures are pre-
sented in Table 2. The modiﬁed Bayescount procedure also pro-
vided inference on the FEC aggregation estimates (k). The pre-
treatment k was modelled as ﬁxed between farms, with an esti-
mate of 0.8 (95% CI 0.6e0.9) for all six herds. In contrast, the post-
treatment k was allowed to vary between farms and there was
evidence for a decrease in post-treatment k (i.e. increased FEC ag-
gregation) in Farms #3, #4 and #6 (Table 2).
The WAAVP and the modiﬁed Bayescount procedures including
the FEC of treated and untreated animals (With CTL) declared
reduced IVM efﬁcacy in farm #2, whereas only the modiﬁed
Bayescount stated reduced drug efﬁcacy in farm #1 (Table 2; With
CTL). Furthermore, the WAAVP and modiﬁed Bayescount proced-
ures (With CTL) indicated efﬁcacious treatment in farm #5, while all
other results were inconclusive. While in analyses including the
Table 1
Faecal egg counts (FEC) of 20 ﬁrst-season grazing calves for each of the 19 Danish
farms sampled during initial screening in the 2013 and 2014 grazing seasons. A total
of 380 ﬁrst-season grazers were examined. Data are presented as arithmetic mean
FEC, range (in egg per gram of faeces, epg) and the date of sampling. Six farms (farms
#1e6) were included in the subsequent faecal egg count reduction tests (FECRT).
Farm Mean FEC (epg) Range (epg) Date of samplingb
1 438 85e975 16 June 2013
2 101 5e205 24 June 2013
3 184 5e730 20 August 2013
4 273 20e960 27 June 2014
5 75 10e225 09 July 2014
6 75 15e215 14 August 2014
7 8 0e40 02 July 2013
8 37 0e135 04 July 2013
9 44 0e135 23 July 2013
10 3 0e30 05 August 2013
11 17 0e80 14 August 2013
12 17 0e60 24 June 2014
13 221a 5e1165 02 July 2014
14 18 0e55 22 July 2014
15 8 0e40 23 July 2014
16 6 0e25 15 August 2014
17 3 0e20 25 August 2014
18 2 0e10 26 August 2014
19 11 0e40 07 September 2014
a Despite high FEC this farmer did not want to participate in the FECRT.
b Turn-out of grazing cattle in Denmark is usually around late April/early May.
Table 2
Faecal egg count reduction test in calves naturally infected with gastrointestinal nematodes in six Danish cattle farms. A total of 115 ﬁrst-season grazers were sampled on the
day of treatment (Day 0) and 14 days post-treatment (Day 14). The calves were treated with ivermectin (IVM, 0.2 mg kg1 body weight s.c.) or left untreated (CTL). Treatment
efﬁcacies were calculated including the variation of faecal egg counts (FEC) in treated and control groups (With CTL) or in treated groups only (No CTL). Total post-treatment FEC
aggregation estimates (k) for each farm are shown according to the modiﬁed Bayescount.
Farm #1 (Beef,
conv.)
Farm #2 (Dairy,
org.)
Farm #3 (Dairy,
conv.)
Farm #4 (Dairy,
org.)
Farm #5 (Beef, org.) Farm #6 (Dairy, org.)
Group IVM CTL IVM CTL IVM CTL IVM CTL IVM CTL IVM CTL
n 10 10 10 10 10 10 10 9 10 10 7 9
FEC Day 0 333 325 76 69 173 209 354 351 55 39 31 77
FEC Day 14 46 311 14 55 15 286 51 562 4 98 4 126
k 0.7 (0.4e0.9) 0.7 (0.1e1.0) 0.3 (0.1e0.6) 0.3 (0.2e0.5) 1.0 (0.6e1.4) 0.2 (0.1e0.4)
With CTL FECR% [CI] FECR% [CI] FECR% [CI] FECR% [CI] FECR% [CI] FECR% [CI]
WAAVPa 85I [67e95] 75R [27e92] 95I [56e99] 91I [74e97] 96E [92e99] 97I [65e99]
Bayescountb 87R [80e94] 78R [61e92] 93I [70e99] 91I [73e99] 96E [92e99] 90I [52e99]
No CTL FECR% [CI] FECR% [CI] FECR% [CI] FECR% [CI] FECR% [CI] FECR% [CI]
WAAVPa 86R [66e94] 82R [47e94] 92I [30e99] 86R [67e94] 94I [87e97] 83I [50e98]
Bayescountb 87R [81e93] 83R [72e92] 90I [62e98] 81R [50e94] 92I [84e98] 81I [25e99]
eggCountsc 84R [55e94] 80R [50e91] 86I [21e98] 83R [47e94] 93I [82e97] 83I [22e97]
FEC ¼ arithmetic mean faecal egg count; k ¼ total post-treatment FEC aggregation estimate; FECR% ¼ FEC reduction percentage; CI ¼ 95% conﬁdence interval.
EEfﬁcacious; RReduced efﬁcacy; IInconclusive; conv. ¼ conventional; org. ¼ organic.
a Coles et al. (1992).
b Modiﬁed Bayescount (paired model with pooled between-animal and within-animal pre-treatment k).
c eggCounts unpaired model (Torgerson et al., 2014).
M. Pe~na-Espinoza et al. / International Journal for Parasitology: Drugs and Drug Resistance 6 (2016) 241e250 245
FEC ﬂuctuations in the treated groups only (No CTL), the WAAVP,
modiﬁed Bayescount and eggCounts procedures unanimously
indicated reduced IVM efﬁcacy in farms #1, #2 and #4. All methods
(No CTL) yielded inconclusive results in farms #3, #5 and #6
(Table 2; No CTL).
3.3. Real-time qPCR for detection of O. ostertagi and C. oncophora
Proportions of ITS-2 copies of O. ostertagi and C. oncophora
detected in pre- and post-treatment pooled larval cultures in the
FECRT are presented in Table 3. At Day 0, O. ostertagi and
C. oncophora ITS-2 copies were detected in both groups from all
farms, with the exception of the CTL group in farm #2, where only
C. oncophora was identiﬁed. Post-treatment, O. ostertagi ITS-2
copies were detected only in IVM groups of farms #3 and #4,
while C. oncophora ITS-2 copies were identiﬁed in treated groups
from all six farms. Ampliﬁcation efﬁciencies of the standard curves
were 96% and 100% for C. oncophora and O. ostertagi, respectively,
with correlation coefﬁcients (R2) of 0.99 for both species.
3.4. Anthelmintic prescriptions in the farms selected for FECRT
The anthelmintic prescriptions between 2002 and 2012 in the
six farms selected for FECRT and the estimated number of animals
treated are shown in Supplementary Table 1. Prescriptions with
anthelmintics other than MLs were rarely observed (only in farm
#2 with albendazole and farm #3 with levamisole). In calves from
all six farms, IVM was the most commonly used ML (87.2% of all
prescriptions), followed by moxidectin (12.8%). Similarly, IVM was
the predominant ML used in young cattle (84.7% of all pre-
scriptions), followed by moxidectin (14.7%). In adult cattle, IVM
constituted 61.5% of all prescriptions in farms #2, #3, #4 and #6,
followed by eprinomectin (23.8%) and moxidectin (12.5%). No adult
cattle were recorded in farms #1 and #5 during the period. Topical
(pour-on) drugs were the predominant formulations used in all six
farms (98.6%, 95.1% and 88.4% of all prescribed treatments in calves,
young and adult cattle, respectively). In general, treatments were
prescribed at irregular intervals in all farms throughout the decade
preceding the FECRT, and 61% of all prescriptions were estimated to
have been targeted to less than 50% of the animals in a given age
group. Nevertheless, evidence suggesting whole-group treatments
was observed at all farms, particularly farm #1 (the only conven-
tional beef herd in the study) and farm #6 (organic dairy farm).
There were no marked differences in the prescription patterns
between beef and dairy or conventional and organic farms.
3.5. Simulation study
The performance of the different procedures used to estimate
drug efﬁcacy in the FECRT is presented in Table 4. The coverage
probability of the 95% CI describes the ability of each procedure to
correctly include the simulated FECR% in the generated CI under
varying degrees of FEC aggregation (simulated total post-treatment
k). The target coverage of the 95% CI is expected to be close to 95%.
Whereas the uncertainty of the 95% CI is deﬁned as the average
difference between the upper and lower 95% CI generated by the
procedure with each dataset, with a smaller uncertainty repre-
senting (on average) a narrower 95% CI, and therefore the dataset is
less likely to be classiﬁed as inconclusive. The WAAVP method had
good coverage for most parameter sets, although this was lower for
the datasets with very low post-treatment k, regardless of sample
size and FECR% (Table 4). The eggCounts paired model had
consistently lower coverage probabilities compared with the un-
paired model, at all levels of post-treatment k, sample size and
FECR% within the conditions simulated. The unpaired eggCounts
procedure had good coverage for most datasets and reduced un-
certainty compared to the Bayescount procedure, which reﬂects the
assumption that FEC aggregation in post-treatment data is the
same as that in the pre-treatment data. However, where this
assumption was strongly violated by high post-treatment aggre-
gation (post-treatment k ¼ 0.1), then coverage of the unpaired
eggCounts method dropped to 76% for the highest sample size. The
95% CI provided by the Bayescount procedure had good coverage
for all parameter sets, although generally higher uncertainty than
the other procedures for the 97% simulated FECR%.
Coverage and uncertainty of the 95% CI generated by all pro-
cedures increased or decreased, respectively, following the increase
in group size in both simulated FECR% scenarios (Table 4). Based on
results with the WAAVP method (which generally gives a good
balance between coverage and uncertainty), and applying the
classiﬁcation criteria described in Section 2.7, the minimum sample
size that is required before 80% of datasets with a FECR ¼ 97% can
be correctly classiﬁed as efﬁcacious treatment is n ¼ 20 for
moderately increased FEC aggregation (pre and post-treatment
k ¼ 0.8 and 0.3, respectively) or n ¼ 40 for extremely increased
FEC aggregation (pre and post-treatment k ¼ 0.8 and ¼ 0.1, corre-
spondingly; data not shown). Similarly, to give an 80% chance of
correctly classifying datasets with a FECR¼ 85% as reduced efﬁcacy,
a minimum of n ¼ 20 is required for no increase in post-treatment
aggregation, or n ¼ 30 for moderately increased aggregation. With
extreme increases in aggregation, even a sample size of n ¼ 40 may
be expected to give inconclusive results approximately 50% of the
time (data not shown).
4. Discussion
In the FECRT, reduced IVM efﬁcacy was detected in three farms
by all analyses based on the FEC of treated cattle only, and in one
farm according to both procedures including the FEC from treated
and untreated animals. Post-treatment, O. ostertagi and
C. oncophora L3 were identiﬁed in faeces of treated animals in one
and three farms with declared reduced IVM efﬁcacy, respectively.
This is the ﬁrst report of reduced anthelmintic efﬁcacy in Danish
cattle.
During the initial screening prior to the FECRT, FSG calves with
mean FEC <100 epg were detected in most farms. Similar obser-
vations were reported in untreated FSG calves from Belgium, Ger-
many (El-Abdellati et al., 2010) and France (Geurden et al., 2015). At
Table 3
Proportion (percentage) of the second internal transcriber space (ITS-2) copy
numbers of Ostertagia ostertagi and Cooperia oncophora detected by real-time
quantitative PCR in pooled L3 cultured from faeces of naturally infected calves. The
calves were treated with the recommended dose of injectable ivermectin (IVM) or
left untreated (CTL). The samples were collected on the day of treatment (Day 0) and
14 days post-treatment (Day 14).
Farm Group Day 0 Day 14
O.o. C.o. O.o. C.o.
#1 IVM 42 58 0 100
CTL 39 61 57 43
#2 IVM 79 21 0 100
CTL 0 100 2 98
#3 IVM 45 55 85 15
CTL 78 22 74 26
#4 IVM 8 92 0.5 99.5
CTL 17 83 6 94
#5 IVM 42 58 0 100
CTL 84 16 0 100
#6 IVM 3 97 0 100
CTL 6 94 0 100
O.o. ¼ Ostertagia ostertagi; C.o. ¼ Cooperia oncophora.
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Day 0 of the FECRT, three farms had a mean FEC <150 epg (farms
#4, #5 and #6), which was a consequence of our initial selection of
farms with mean FEC  75 epg. Although the use of a FEC method
with high sensitivity (5 epg in the present study) reduces the
diagnostic uncertainty in samples with low FEC (El-Abdellati et al.,
2010; Levecke et al., 2011), a low mean FEC pre-treatment will
likely affect the outcome of a FECRT, particularly when group
size  10 and FEC are highly aggregated (Levecke et al., 2012).
Therefore, the reduced drug efﬁcacy detected in Danish farms with
initial mean FEC <150 epg should preferably be conﬁrmed by new
FECRTs including cattle with higher egg excretion.
The qPCR method applied in the present study was able to
detect ITS-2 copies of O. ostertagi and C. oncophora in pooled larval
cultures from naturally infected cattle, as earlier reported by
Areskog et al. (2013). In agreement with previous European reports
(Demeler et al., 2009; Geurden et al., 2015), C. oncophora was the
predominant species surviving IVM treatment in all farms with
reduced drug efﬁcacy. This result was expected as C. oncophora is
the dose-limiting GIN for IVM (Egerton et al., 1981). The more
pathogenic O. ostertagi was detected in IVM groups from all six
farms at Day 0 and from two farms at Day 14. However, reduced
efﬁcacy by all methods (No CTL) was only detected in one of these
farms (#4), therefore the possible presence of an IVM-resistant
O. ostertagi in this herd should be further conﬁrmed. The absence
of O. ostertagi L3 in post-treatment cultures from most farms re-
ﬂects the expected high efﬁcacy of injectable IVM against this
abomasal species (Egerton et al., 1981; Lifschitz et al., 2000).
Nevertheless, the examination of pooled L3, the low FEC of samples
and the poor yield of L3 following culture may have been masking
the true ratio of the species surviving treatment. Individual larval
cultures could have increased the sensitivity of the test and resulted
in a different outcome, however, this was not possible within the
timeframe of the study. A practical limitation for the routine use of
infective larvae for species detection is the time required to culture
L3 and the well-known variability in developmental requirements
of different nematodes in larval cultures (Roeber and Kahn, 2014).
As alternative, other nematode stages could be used for species-
speciﬁc detection by molecular techniques (Harmon et al., 2006),
and recent studies from our group have explored this by effectively
quantifying ITS-2 copies in eggs and ﬁrst-stage larvae of O. ostertagi
(Drag et al., 2016).
In the FECRT, methods of calculation that included the FEC of
untreated animals resulted in a higher number of inconclusive re-
sults, in comparison with methods excluding the CTL group. The
inclusion of untreated animals in a FECRT has been recommended
to detect changes in the FEC of a herd not related with the treat-
ment, and for the correction of such ﬂuctuations in the estimation
of drug efﬁcacy (Coles et al., 1992; Lyndal-Murphy et al., 2014).
However, the inclusion of a control group is based on the
assumption that treated and untreated animals with comparable
FEC share similar worm burdens, which may not be always the case
in cattle (Michel, 1967, 1969). Moreover, the density-dependent
control of fecundity in some bovine nematodes, such as in
O. ostertagi, may reduce the FEC in untreated animals due to newly
acquired infections and could increase the egg excretion of female
worms in treated groups due to lower worm burden and
Table 4
Coverage probabilities and uncertainty of 95% conﬁdence intervals (CI) provided by the WAAVP, eggCounts (paired and unpaired model) and Bayescount (standard paired
model) procedures with datasets of simulated FECR ¼ 85% or 97% and with varying group sizes (n) and total post-treatment aggregation estimate (k). Results are presented as
the percentage of iterations in which the simulated FECR% was correctly included within the 95% CI provided by the procedure. A total of 500 iterations were performed for
each combination of true FECR% and k. See text for further details on the simulated parameters.
Coverage 95% CI Uncertainty 95% CI
FECR% ¼ 85% WAAVPa eggCountsb Bayescountc WAAVPa eggCountsb Bayescountc
n k paired unpaired paired unpaired
10 0.1 82 23 80 95 65 8 45 74
0.3 95 40 96 99 49 9 45 51
0.8 98 63 99 100 34 9 36 32
20 0.1 88 26 82 97 45 6 34 60
0.3 94 39 94 95 31 6 27 30
0.8 100 64 99 99 23 6 22 17
30 0.1 90 22 84 96 40 5 29 50
0.3 96 44 95 95 25 5 21 20
0.8 100 67 100 99 18 5 17 13
40 0.1 91 22 81 97 34 4 23 40
0.3 97 39 94 96 22 4 18 17
0.8 100 64 99 97 16 4 15 10
Coverage 95% CI Uncertainty 95% CI
FECR% ¼ 97% WAAVPa eggCountsb Bayescountc WAAVPa eggCountsb Bayescountc
n k paired unpaired paired unpaired
10 0.1 84 49 85 99 15 4 14 68
0.3 93 67 93 100 10 4 11 38
0.8 98 85 99 100 9 4 10 18
20 0.1 87 46 79 97 11 3 7 43
0.3 96 74 96 99 7 3 6 11
0.8 98 83 99 99 5 3 5 5
30 0.1 89 43 78 95 8 2 5 25
0.3 96 68 94 97 5 2 4 6
0.8 99 83 99 98 4 2 4 4
40 0.1 90 44 76 95 7 2 4 15
0.3 97 70 94 95 5 2 4 4
0.8 98 82 98 97 4 2 3 3
a Coles et al. (1992).
b Torgerson et al. (2014).
c Geurden et al. (2015); FECR% ¼ Simulated faecal egg count reduction; n ¼ simulated group size; k ¼ simulated total post-treatment FEC aggregation estimate.
M. Pe~na-Espinoza et al. / International Journal for Parasitology: Drugs and Drug Resistance 6 (2016) 241e250 247
competition (Dobson et al., 2012). In practice, when few animals are
available for a FECRT, the inclusion of a control group will limit the
size of the treatment group and consequently increase uncertainty
of the estimated efﬁcacy (Denwood et al., 2010). The low number of
FSG calves with positive FEC that could be included in our study
suggests that in these circumstances, the inclusion of untreated
cattle in the FECRT should not be recommended. Instead, it may be
advisable to include more animals in the treatment group in order
to increase the certainty of the calculated FECR% (Denwood et al.,
2010; Levecke et al., 2012), a similar conclusion derived from our
simulation study.
The simulation study showed the difﬁculties of analysing FECRT
data, evenwith sophisticatedmethods such as that implemented in
eggCounts and Bayescount. The poor coverage of 95% CI produced
by the paired eggCounts procedure suggests (based on our simu-
lations) that the eggCounts unpaired model should be preferred,
even when analysing paired data such as that simulated here. Both
eggCounts models were also tested with the use of the zero-
inﬂation option, but results were qualitatively similar to those
without zero-inﬂation (data shown). The relatively simple WAAVP
procedure showed a better coverage probability than most of the
other procedures, but does have the limitation of not providing a
95% CI when post-treatment FEC are zero (Denwood et al., 2010;
Torgerson et al., 2014; Geurden et al., 2015). Only the Bayescount
procedure was able to consistently identify the simulated FECR%
within the 95% CI produced, although this comes at the cost of
increased uncertainty. The results also suggest that a treatment
group of n ¼ 10 is inadequate for cattle, and also support the ob-
servations of Gill et al. (1986) that the minimum required sample
size depends strongly on the degree of aggregation that is assumed.
Given these complications, new statistical methods are needed to
quickly determine the prospective study power of a given animal
group size, mean FEC and aggregation parameters. However,
despite the limited sample size available in the FECRT studies, we
were able to modify the paired Bayescount model to make use of
the available data from the initial screening and use of pooled
variance parameters to bolster the inference of the model. This
produced substantially reduced 95% CI relative to the indepen-
dently modelled datasets using the same procedure (data not
shown), and is therefore highly recommended as a way to maxi-
mise the utility of MCMC for these types of data. A second beneﬁt of
this approach is that the variability parameters themselves may
give useful information; in this case, there is a strong suggestion
that the change in FEC aggregation post-treatment is more sub-
stantial in some farms than others. If this is due to variation in ef-
ﬁcacy between animals, then a large post-treatment change in
variability could itself indicate the early signs of developing AR. It is
also possible to incorporate moderately informative priors into
models ﬁt using Bayesian MCMC as a way of maximising the
inference from the data. Informative priors were explored as part of
the modiﬁed Bayescount model presented, but ultimately did not
provide any more information than the minimally informative
priors. Moderately informative priors are used by eggCounts, and
these are certainly valid in the context given by Paul et al. (2014),
but care should be taken when using these models for different
datasets to ensure that the priors are appropriate in the situation at
hand. If the use of these methods is attempted without some un-
derstanding of the theory and application of MCMC, then the po-
tential for erroneous inference is extremely large due to either
selection of inappropriate model formulations (including prior se-
lection) or errors introduced by poor convergence and/or high
autocorrelation (Brooks and Roberts, 1998; Kass et al., 1998; Toft
et al., 2007). We therefore strongly recommend that users
without the necessary statistical experience seek assistance with
implementation and interpretation of both the eggCounts and
Bayescount procedures, although when correctly applied these
methods can be used to maximise the information available from
the data by incorporating additional data sources and using tech-
niques such as partial pooling. There is also substantial scope for
the development of a procedure that is simpler in application and
interpretation than MCMC, but until such method is available, our
results support the continued use of the WAAVP method to analyse
FECRT in cattle where mean post-treatment FEC are greater than
zero and statistical expertise is not available.
At the recommended dose of 0.2 mg kg1 BW, injectable IVM is
expected to reduce susceptible O. ostertagi adults and L4 stages
by  99% and susceptible C. oncophora adults and L4 stages
by  97% (Egerton et al., 1981). However, the current WAAVP
guidelines suggests that any treatment with a FECR >90% in cattle
should not be considered a case of drug resistance (Coles et al.,
1992). In practice, most studies evaluating anthelmintic efﬁcacy
in cattle declare AR when FECR <95% and lower 95% CI < 90, as
proposed for sheep. Nevertheless, it has been suggested that this
criteria is biased towards declaration of AR when there is none,
particularly if the mean FECR% is between 90e95% and the CI is
wide (Lyndal-Murphy et al., 2014). In the present study, we
included the upper 95% CI in the interpretation of the FECRT to
increase the certainty of detecting true cases of IVM inefﬁcacy. A
similar interpretation for FECRT studies in cattle has been reported
in recent investigations by Geurden et al. (2015) and Ramos et al.
(2016). However, the effect of including the upper 95% CI in the
interpretation for estimating drug efﬁcacy using a FECRT, and how
this correlates with an actual resistant phenotype conﬁrmed by
controlled efﬁcacy tests, warrant further investigation. It is also
important to note that a reduced FECR% may not necessarily be
caused by AR. A lower-than-expected in vivo efﬁcacy, or varying
drug response between animals, could be the result of under dosing
(e.g. due to inaccurate estimation of BW) and/or altered drug
pharmacokinetics and pharmacodynamics in different animals (e.g.
due to nutrition-related variations in fat reserves that may affect
the persistent efﬁcacy of ML, erratic absorption of drugs from the
site of injection and/or interactions with other co-administered
drugs) (Gonzalez Canga et al., 2008; El-Abdellati et al., 2010; Are-
skog et al., 2012, 2014; De Graef et al., 2013). These factors can
impair the correct estimation of drug efﬁcacy and detection of AR,
particularly in the dose-limiting species C. oncophora. Recently,
C. oncophora populations that were declared resistant to the rec-
ommended dose of injectable IVM by FECRT in two Swedish cattle
farms (with FECR% [upper CI] ¼ 78% [97%] and 79% [98%] in each
farm; Demeler et al., 2009) were declared IVM-susceptible when
tested in calves under controlled conditions (Areskog et al., 2014).
Therefore, the presence of IVM-resistant nematodes suggested by
our FECRT in three farms, as well as the AR status in the farms with
inconclusive results and low initial FEC, should be conﬁrmed by
controlled efﬁcacy test.
The use of anthelmintics in the farms included in our FECRT was
investigated to potentially detect trends in drug use and the extent
of treatments with avermectins. Data was retrieved from the Vet-
Stat database and used to estimate the number of animals treated
with a given anthelmintic at each prescription. However, the actual
number of cattle treated at each investigated prescription is un-
known and our analysis aimed only to offer a rough estimate of the
anthelmintic use in these farms. Furthermore, VetStat does not
register whether adult cattle are lactating or not at the time of
treatment, and therefore the prescription of drugs not allowed for
treatment of animals in lactation (e.g. IVM, levamisole) recorded in
some of the studied farms deserves further investigation. Based on
the data retrieved from VetStat, most of the anthelmintics
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prescribed in the six farms between 2002 and 2012 were aver-
mectins, mostly topical IVM products. A similar reliance on aver-
mectins has been preliminarily detected in the entire Danish cattle
population in the period 2010e2014, constituting ~80% of all
treatments e of which 79% were IVM, mainly in topical formula-
tions (Pe~na-Espinoza et al., unpublished data). The irregular pre-
scription of anthelmintics observed in the study farms correlates
with the prescription-only regulations in Denmark, illustrated by
the treatment of single animals or selected groups of animals in the
herds. However, prescription patterns suggesting whole-group
treatments in some farms indicate that these may be recom-
mended by veterinarians under certain conditions (e.g. during
outbreaks of dictyocaulosis), and the effect of this practice on the
selection for AR needs further investigation. All treatments against
GIN in Denmark should be based on a clinical and/or laboratory
examination, and preventive/strategic anthelmintic treatments
without such diagnosis are illegal. Organic farms are further
encouraged to apply other means of parasite control than use of
anthelmintics; however, due to limited knowledge of alternative
and effective parasite control methods, most farms (whether
organic or not) still rely on anthelmintic drugs. Therefore, and
considering the relevance of IVM and other anthelmintics for
nematode control in Danish cattle, the true extent of AR in bovine
nematodes in Denmark needs to be assessed in larger surveys. Until
then, producers and veterinarians should be aware of potentially
ineffective treatments against GIN in cattle, while reducing the
reliance on anthelmintics by including other parasite control stra-
tegies with documented efﬁcacy, such as grazing management and
feeding with bioactive forages (Nansen et al., 1987; Pe~na-Espinoza
et al., 2016).
In conclusion, reduced IVM efﬁcacy was detected by all methods
for analysis of FECRT data excluding untreated controls in three of
six Danish cattle farms investigated. Cooperia oncophora was the
main species surviving IVM treatment in three farms with
conﬁrmed reduced drug efﬁcacy, while O. ostertagi was also iden-
tiﬁed post-treatment by qPCR in one farm with reduced IVM efﬁ-
cacy. Nevertheless, the presence of IVM-resistant nematode strains
suggested by the FECRT should preferably be conﬁrmed by
controlled efﬁcacy test. The reduced efﬁcacy of IVM detected in this
study and the widespread use of ML drugs in Danish cattle suggest
that farmers and their advisors should be aware of potentially
ineffective treatments and larger surveys are warranted to describe
the true extent of the problem. However, further validation of the
design and analysis of the FECRT in cattle are urgently needed
before such surveys can be implemented in cattle farms.
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